Skip to main content
. 2019 Jul 24;10:495. doi: 10.3389/fendo.2019.00495

Figure 2.

Figure 2

(A) Circulation levels of ANGPTL5 in non-obese (n = 70) vs. obese subjects (n = 39) as measured by ELISA in non-diabetic people. (B) Circulation levels of ANGPTL5 in non-obese (n = 34) vs. obese subjects (n = 61) as measured by ELISA in people with T2D. P < 0.05 was considered significant as determined using student's t-test. (C) Circulation levels of ANGPTL5 in non-obese non-T2D (n = 70), obese non-T2D (n = 39), and obese T2D (n = 61) as measured by ELISA. P < 0.05 was considered significant as determined using one-way ANOVA.